SZLD Biomaterials Technology Corporation was founded by several doctors from Tsinghua University and has raised over 670 million yuan in total.
The company has applied for 105 domestic and foreign patents, and has obtained 68 authorizations. Some core products have obtained medical device registration certificates and are listed on the market.
After 8 years of research and development, the double-layer artificial dermis repair material was approved by the National Medical Products Administration (NMPA) as a Class III medical device registration certificate in August 2017, filling the gap in China. After more than five years of market promotion, artificial dermis has become a leading brand in China and is widely used in hundreds of Class 3 first-class hospitals, saving tens of thousands of patients every year.
In June 2021, the oral absorbable biofilm product developed by the company obtained the Class III medical device registration certificate approved by NMPA. Many key indicators of this product are better than imported products, and it has an international leading level. At the same time, core products in a number of sub-sectors have successively entered the clinical trial stage.